Spelsberg and colleagues showed that ascertaining the results of post-marketing safety studies is challenging.1 In the US and Europe, brand name drug manufacturers are required to summarise data from...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2p5g7kF
via
IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου